1. OP2 Prophylactic, N-Acetylcysteine unsuccessful in influencing plasma antioxidant capacity in a parallel-group randomized controlled trial of patients with chronic kidney disease stage III; implications for contrast induced nephropathy. (5th April 2020) Authors: Raja, KI; Hickson, K; Treweeke, AT; Rushworth, G; Morrison, E; Sandilands, E; Cobley, JN; McEneaney, D; Eddleston, M; Megson, IL Journal: Heart Issue: Volume 106(2020)Supplement 1 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P9 N-actylcysteine fails to impact on plasma antioxidant status in a placebo controlled crossover study in healthy volunteers and patients with chronic kidney disease: implications for its value in preventing contrast-induced nephropathy. (May 2019) Authors: Raja, KI; Hickson, K; Treweeke, AT; Rushworth, G; Morrison, E; Sandilands, E; Cobley, JN; McEneaney, D; Eddleston, M; Megson, IL Journal: Heart Issue: Volume 105(2019)Supplement 4 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗